Discogenic Pain — Bone Marrow Concentrate Intradiscal Injection for Chronic Discogenic Low Back Pain
Citation(s)
Barendse GA, van Den Berg SG, Kessels AH, Weber WE, van Kleef M Randomized controlled trial of percutaneous intradiscal radiofrequency thermocoagulation for chronic discogenic back pain: lack of effect from a 90-second 70 C lesion. Spine (Phila Pa 1976). 2001 Feb 1;26(3):287-92.
Carragee EJ, Don AS, Hurwitz EL, Cuellar JM, Carrino JA, Herzog R 2009 ISSLS Prize Winner: Does discography cause accelerated progression of degeneration changes in the lumbar disc: a ten-year matched cohort study. Spine (Phila Pa 1976). 2009 Oct 1;34(21):2338-45. doi: 10.1097/BRS.0b013e3181ab5432. Erratum in: Spine (Phila Pa 1976). 2010 Jun 15;35(14):1414. Carrino, John [corrected to Carrino, John A].
Centeno C, Pitts J, Al-Sayegh H, Freeman M Efficacy of autologous bone marrow concentrate for knee osteoarthritis with and without adipose graft. Biomed Res Int. 2014;2014:370621. doi: 10.1155/2014/370621. Epub 2014 Sep 7.
Centeno CJ, Al-Sayegh H, Bashir J, Goodyear S, Freeman MD A prospective multi-site registry study of a specific protocol of autologous bone marrow concentrate for the treatment of shoulder rotator cuff tears and osteoarthritis. J Pain Res. 2015 Jun 5;8:269-76. doi: 10.2147/JPR.S80872. eCollection 2015.
Centeno CJ, Al-Sayegh H, Freeman MD, Smith J, Murrell WD, Bubnov R A multi-center analysis of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous stem cell therapy for orthopaedic conditions. Int Orthop. 2016 Aug;40(8):1755-1765. doi: 10.1007/s00264-016-3162-y. Epub 2016 Mar 30. Erratum in: Int Orthop. 2018 Jan;42(1):223.
Chahla J, Dean CS, Moatshe G, Pascual-Garrido C, Serra Cruz R, LaPrade RF Concentrated Bone Marrow Aspirate for the Treatment of Chondral Injuries and Osteoarthritis of the Knee: A Systematic Review of Outcomes. Orthop J Sports Med. 2016 Jan 13;4(1):2325967115625481. doi: 10.1177/2325967115625481. eCollection 2016 Jan.
Connolly JF, Guse R, Tiedeman J, Dehne R Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res. 1991 May;(266):259-70.
DePalma MJ, Ketchum JM, Saullo T What is the source of chronic low back pain and does age play a role? Pain Med. 2011 Feb;12(2):224-33. doi: 10.1111/j.1526-4637.2010.01045.x. Epub 2011 Jan 25.
Freeman BJ, Fraser RD, Cain CM, Hall DJ, Chapple DC A randomized, double-blind, controlled trial: intradiscal electrothermal therapy versus placebo for the treatment of chronic discogenic low back pain. Spine (Phila Pa 1976). 2005 Nov 1;30(21):2369-77; discussion 2378.
Fritzell P, Hägg O, Wessberg P, Nordwall A; Swedish Lumbar Spine Study Group 2001 Volvo Award Winner in Clinical Studies: Lumbar fusion versus nonsurgical treatment for chronic low back pain: a multicenter randomized controlled trial from the Swedish Lumbar Spine Study Group. Spine (Phila Pa 1976). 2001 Dec 1;26(23):2521-32; discussion 2532-4.
Ghahreman A, Ferch R, Bogduk N The efficacy of transforaminal injection of steroids for the treatment of lumbar radicular pain. Pain Med. 2010 Aug;11(8):1149-68. doi: 10.1111/j.1526-4637.2010.00908.x.
Golish SR, Hanna LS, Bowser RP, Montesano PX, Carragee EJ, Scuderi GJ Outcome of lumbar epidural steroid injection is predicted by assay of a complex of fibronectin and aggrecan from epidural lavage. Spine (Phila Pa 1976). 2011 Aug 15;36(18):1464-9. doi: 10.1097/BRS.0b013e3181f40e88.
Hanley EN Jr, David SM Lumbar arthrodesis for the treatment of back pain. J Bone Joint Surg Am. 1999 May;81(5):716-30. Review.
Holton J, Imam M, Ward J, Snow M The Basic Science of Bone Marrow Aspirate Concentrate in Chondral Injuries. Orthop Rev (Pavia). 2016 Sep 30;8(3):6659. eCollection 2016 Sep 19.
Kamper SJ, Ostelo RW, Knol DL, Maher CG, de Vet HC, Hancock MJ Global Perceived Effect scales provided reliable assessments of health transition in people with musculoskeletal disorders, but ratings are strongly influenced by current status. J Clin Epidemiol. 2010 Jul;63(7):760-766.e1. doi: 10.1016/j.jclinepi.2009.09.009. Epub 2010 Jan 8.
Kang CH, Kim YH, Lee SH, Derby R, Kim JH, Chung KB, Sung DJ Can magnetic resonance imaging accurately predict concordant pain provocation during provocative disc injection? Skeletal Radiol. 2009 Sep;38(9):877-85. doi: 10.1007/s00256-009-0709-7. Epub 2009 May 9. Erratum in: Skeletal Radiol. 2010 Feb;39(2):207.
Kolahi J, Bang H, Park J Towards a proposal for assessment of blinding success in clinical trials: up-to-date review. Community Dent Oral Epidemiol. 2009 Dec;37(6):477-84. doi: 10.1111/j.1600-0528.2009.00494.x. Epub 2009 Sep 15. Review.
Levi D, Carnahan D, Horn S, Levin J Is a History of Severe Episodic Low Back Pain an Indicator of a Discogenic Etiology? Pain Med. 2018 Jul 1;19(7):1334-1339. doi: 10.1093/pm/pnx147.
Levi D, Horn S, Corcoran S The Incidence of Intradiscal, Intrathecal, and Intravascular Flow During the Performance of Retrodiscal (Infraneural) Approach for Lumbar Transforaminal Epidural Steroid Injections. Pain Med. 2016 Aug;17(8):1416-22. doi: 10.1093/pm/pnv067. Epub 2015 Dec 24.
Levi D, Horn S, Tyszko S, Levin J, Hecht-Leavitt C, Walko E Intradiscal Platelet-Rich Plasma Injection for Chronic Discogenic Low Back Pain: Preliminary Results from a Prospective Trial. Pain Med. 2016 Jun;17(6):1010-22. doi: 10.1093/pm/pnv053. Epub 2015 Dec 26.
Levi DS, Horn S, Walko E Intradiskal methylene blue treatment for diskogenic low back pain. PM R. 2014 Nov;6(11):1030-7. doi: 10.1016/j.pmrj.2014.04.008. Epub 2014 Apr 26.
Naqvi SM, Buckley CT Bone Marrow Stem Cells in Response to Intervertebral Disc-Like Matrix Acidity and Oxygen Concentration: Implications for Cell-based Regenerative Therapy. Spine (Phila Pa 1976). 2016 May;41(9):743-50. doi: 10.1097/BRS.0000000000001314.
Nguyen RT, Borg-Stein J, McInnis K Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R. 2011 Mar;3(3):226-50. doi: 10.1016/j.pmrj.2010.11.007. Review.
Peng B, Pang X, Wu Y, Zhao C, Song X A randomized placebo-controlled trial of intradiscal methylene blue injection for the treatment of chronic discogenic low back pain. Pain. 2010 Apr;149(1):124-9. doi: 10.1016/j.pain.2010.01.021. Epub 2010 Feb 18.
Peng B, Zhang Y, Hou S, Wu W, Fu X Intradiscal methylene blue injection for the treatment of chronic discogenic low back pain. Eur Spine J. 2007 Jan;16(1):33-8. Epub 2006 Feb 22.
Pettine K, Suzuki R, Sand T, Murphy M Treatment of discogenic back pain with autologous bone marrow concentrate injection with minimum two year follow-up. Int Orthop. 2016 Jan;40(1):135-40. doi: 10.1007/s00264-015-2886-4. Epub 2015 Jul 10.
Pettine KA, Murphy MB, Suzuki RK, Sand TT Percutaneous injection of autologous bone marrow concentrate cells significantly reduces lumbar discogenic pain through 12 months. Stem Cells. 2015 Jan;33(1):146-56. doi: 10.1002/stem.1845.
Shapiro SA, Kazmerchak SE, Heckman MG, Zubair AC, O'Connor MI A Prospective, Single-Blind, Placebo-Controlled Trial of Bone Marrow Aspirate Concentrate for Knee Osteoarthritis. Am J Sports Med. 2017 Jan;45(1):82-90. doi: 10.1177/0363546516662455. Epub 2016 Sep 30.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
